KRAS and non-small cell lung carcinoma: Given that the K-Ras mutation inhibits the expression of miR-199b and that the inhibition of miR-199b promotes NSCLC progression, we hypothesized that restoring miR-199b could suppress K-Ras-mutated NSCLC.